HIGHMARK, INC. for HIGHMARK INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
COVID-19 Testing; Rx reform; Prescription drugs; Prescription Drug Reform; OTC COVID Tests; Insulin; H.R. 3 - Lower Drug Costs Now Act Sponsor: Rep. Frank Pallone (D-NJ-06) H.R.6833 - Affordable Insulin Now Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
Health Issues HCR
Affordable Care Act (ACA); Health Reform; Mental Health; MHP Audits; COVID-19; Telehealth; Extending ARPA Subsidies; Social Determinants of Health; Pandemic preparedness; OTC Covid Testing; Public Health Emergency; CARES Act Rural Hospital Funding Public Law 117-2 (H.R. 1319) - American Rescue Plan Act of 2021 Sponsor: Rep. John Yarmuth (D-KY-03) H.R. 5376 - Build Back Better Act Sponsor: Rep. John Yarmuth (D-KY-03)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
Medicare/Medicaid MMM
Medicare; Medicare Advantage; Medicaid redeterminations; Part D Reform; Social Determinants of Health; Sequestration H.R. 4074 - Addressing SDOH in Medicare Advantage
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
Taxation/Internal Revenue Code TAX
ACA Tax Credits
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.